Brinda Desai, MD
Pulmonary Disease · Milwaukee, WINPI 1013394030
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,644 of the $5,941 with a category attached, or 78.2%. Sanofi accounts for 74.0% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $5,354, more than ten times the $138 reported in 2022.
Across 29 payments — averaging $204.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$4K
- AstraZeneca$1K
- Actelion Pharmaceuticals US, Inc.$243
- Inari Medical, Inc.$122
- Baxter Healthcare$63
- GSK$58
- plus $14 from 1 others
What the payments were for
- Consulting fees$4,64478%
- Travel & lodging$1182%
- Food & beverage$1,17920%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 8 | $4,399 |
| AstraZeneca | 2 | $1,041 |
| Actelion Pharmaceuticals US, Inc. | 14 | $243 |
| Inari Medical, Inc. | 1 | $122 |
| Baxter Healthcare | 1 | $63 |
| GSK | 2 | $58 |
| Ambu Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$930
- DUPIXENT$246
- FLOWTRIEVER CATHETER, S$122
- CT THROMBECTOMY SYSTEM KIT$122
How this compares
$5,941 in reported general payments places this provider in the 80th percentile of 247 pulmonary disease providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Milwaukee
- Jonathan KurmanMilwaukee$803K
- Mouhammed RihawiMilwaukee$713K
- Kurt HuMilwaukee$55K
- Julie BillerMilwaukee$52K
- Mark BarashMilwaukee$52K
- Rahul NanchalMilwaukee$42K
- Steven LehMilwaukee$40K
- Ali MusaniMilwaukee$38K
- Michael KatzoffMilwaukee$37K
- Uzair GhoriMilwaukee$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.